Sarah Howell is the founder of Arecor. Arecor has raised $26M in total funding. Latest round: IPO. Based in Cambridge, Country.
Sarah Howell is associated with Arecor, a clinical-stage biotech company based in Cambridge. The company focuses on developing superior therapeutics and reformulated drugs, particularly for diabetes, obesity, and other cardiometabolic diseases. Arecor completed a £20 million IPO in 2021.
Full founder directory · Investor directory · Company funding database · Fundraising library